Challenges in the testing of non-heart-beating cadavers for viral markers: Implications for the safety of tissue donors

Cell and Tissue Banking

Volumn 6, Issue 3, 2005, Pages 171-179

  Padley, David ^a   Ferguson, Morag ^a   Warwick, Ruth M ^b   Womack, Christopher ^c   Lucas, Sebastian B ^d   Saldanha, John ^a,e  

^a NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^b NHSBT   (United Kingdom)

^c PETERBOROUGH DISTRICT HOSPITAL   (United Kingdom)

^d ST THOMAS HOSPITAL   (United Kingdom)

^e ROCHE MOLECULAR SYSTEMS   (United States)

Author keywords

Blood borne infection; Cadaver; HBV; HCV; HIV; NAT; Tissue bank; Viral marker

Indexed keywords

BIOLOGICAL MARKER; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; VIRUS DNA; VIRUS RNA;

ANTIBODY DETECTION; ARTICLE; BIOSAFETY; BLOOD SAMPLING; CADAVER DONOR; DNA EXTRACTION; HUMAN; HUMAN TISSUE; INFECTION RISK; LYMPH NODE; METHODOLOGY; NONHUMAN; NUCLEIC ACID AMPLIFICATION; PRIORITY JOURNAL; RISK ASSESSMENT; SERODIAGNOSIS; TISSUE PRESERVATION; TISSUE TRANSPLANTATION; VIRUS INFECTION;

BIOLOGICAL MARKERS; CADAVER; DNA, VIRAL; HEPATITIS B SURFACE ANTIGENS; HEPATITIS C ANTIBODIES; HIV ANTIBODIES; HIV ANTIGENS; HUMANS; LIVER; LYMPH NODES; NUCLEIC ACID AMPLIFICATION TECHNIQUES; REAGENT KITS, DIAGNOSTIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SAFETY; SEROLOGIC TESTS; TISSUE DONORS;

EID: 25144466953     PISSN: 13899333     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10561-005-5421-9     Document Type: Article

References (25)

1. J. Ball U. Desselberger and H. Whitwell 1991 Long lasting viability of HIV after patient's death The Lancet 338 63 10.1016/0140-6736(91)90063-U
2. N. Berry C. Davis A. Jenkins D. Wood P. Minor G. Schild M. Bottiger H. Holmes and N. Almond 2001 Vaccine safety: Analysis of oral polio vaccine CHAT stocks Nature 410 6832 1046-1047 10.1038/35074176 11323658
3. G. Burtonboye and C. Delloye 1996 Polymerase chain reaction in cadaveric blood and tissues Transplant. Proc 28 2927-2928 8908127
4. M. Busch L. Lee G. Satten D. Henrard H. Farzadegan K. Nelson S. Read R. Dodd and L. Petersen 1995 Time course of detection of viral and antigen and antibody detection markers preceding human immunodeficiency virus type 1 seroconversion: Implication for screening of blood and tissue donors Transfusion 35 91-97 10.1046/j.1537-2995.1995.35295125745.x 7825218
5. P.R. Cieslak K. Hedberg and A.R. Thomas 2003 Hepatitis C virus transmission from an antibody negative organ and tissue donor - United States 2000-2002 MMWR 52 273-276
6. Committee for Proprietary Medicinal Products 1997. Introduction of Genomic Amplification Technology (GAT) for the detection of hepatitis C virus RNA in plasma pools. Addendum for Guidance on Plasma Derived Products CPMP/BWP/390/97.
7. E. Conrad D. Gretch K. Obermeyer M. Moogk M. Sayer J. Wilson and D. Strong 1995 The transmission of hepatitis C virus by tissue transplantation J. Bone Joint Surg 77-A 214-224
8. Council of Europe 2004. Guide to Safety and Quality Assurance for Organs, Tissues and Cells. Council of EuropeISBN ISBN 92-871-5518-6.
9. B.C. Dow 2000 'Noise' in microbiological screening assays Transfusion Med 10 97-106 10.1046/j.1365-3148.2000.00248.x
10. B.C. Dow I. Buchannan H. Munro E.A.C. Follett F. Davidson L.E. Prescott P.L. Yap and P. Simmonds 1996 Relevance of RIBA-3 supplementary test to HCV PCR positivity and genotypes for HCV confirmation of blood donors J. Med. Virol 49 132-136 10.1002/ (SICI)1096-9071(199606)49:2<132::AID-JMV10>3.0.CO;2-G 8991936
11. D.T. Eastlund 1995 Infectious disease transmission through cell, tissue and organ transplantation: Reducing the risk through donor selection Cell Transplant 4 455-477 10.1016/0963-6897(95)00035-V 8520830
12. D.T. Eastlund 2000 Hemodilution due to blood loss and transfusion and reliability of cadaver tissue donor infectious disease testing Cell and Tissue Banking 1 121-127 10.1023/A:1010120115451 15256957
13. Guidelines for Blood Transfusion Services in the UK. Sixth Edition 2002. The Stationary OfficeLondon. (Available at http://www.transfusionguidelines.org.uk).
14. A. Heim D. Wagner T. Rothamel U. Hartmann J. Flik and W. Verhagen 1999 Evaluation of antigen and antibody detection screening of cadaveric sera for donor selection for cornea transplantation J. Med. Virol 58 291-295 10.1002/(SICI)1096-9071(199907)58:3<291::AID-JMV16>3.0.CO;2-D 10447426
15. S. Kleinman M. Busch J. Korelitz and G. Schreiber 1997 The incidence/ window period model and its use to assess the risk of transfusion-transmitted human immunodeficiency virus and hepatitis C virus infection Transfusion Med. Rev 11 155-172 10.1053/tmrv.1997.0110155
16. W.M. LeFor A.F. McGonigle D.L. Wright and D.L. Shires III 1996 The frequency of false positive HBsAg screening test results with cadaver tissue donors is dependent upon the assay procedure used Tissue and Cell Report 3 297-300
17. Martinez O.V. and Malinin T.I. 1996. The effect of postmortem interval and manner of death on blood and bone marrow cultures from non-septic cadaver donors of tissues for transplantation. Abstracts of the 96th Meeting of the American Society for Microbiology. New Orleans, Louisiana
18. H. Meisel 2003 Transmission of hepatitis B virus 2 months prior to hepatitis B surface antigen positivity of donor blood Transfusion Med. Hemotherapy 30 228-231 10.1159/000074288
19. M. Miédougé M. Chatelut and J-M. Mansuy 2002 Screening of blood from potential organ and cornea donors for viruses J. Med. Virol 66 571-575 10.1002/jmv.2183 11857539
20. S.L. Novick J.A. Schrager J.A. Nelson and B.L. Baskin 1993 A comparison of two hepatitis B surface antigen and two human immunodeficiency virus type 1 (p24) antigen enzyme immunoassay kits using hemolyzed cadaveric blood specimens Transfusion 33 619
21. D.J. Padley S.B. Lucas and J. Saldanha 2003 Elimination of false negative HCV RNA results by removal of inhibitors in cadaver donor blood specimens Transplantation 76 2 432-434 10.1097/01.TP.0000072780.66347.B1 12883207
22. J. Saldanha and P. Minor 1996 Collaborative study to assess the suitability of an HCV RNA reference sample for detection of an HCV RNA in plasma pools by PCR Vox Sang 70 148-151 8740006
23. R.J. Simonds S.D. Holmberg and R.L. Hurwitz 1992 Transmission of human immunodeficiency virus type 1 from a seronegative organ and tissue donor NEJM 326 726-732 1738377
24. S.J. Stanworth R.M. Warwick M. Ferguson and J.A. Barbara 2000 A UK Survey of virological testing of cadaver tissue donors Vox Sanguinis 79 227-230 10.1159/000056735 11155074
25. US Department of Health and Human Services, Food and Drug Administation. 2000. Guidance for industry. Availability of Licensed Donor Screening Tests Labelled for use with Cadaveric Blood Specimens http://www.fda.gov/cber/gdlns/cadbld.pdf.